Attached files

file filename
10-K - FORM 10-K - CYTOKINETICS INCf54965e10vk.htm
EX-23.1 - EX-23.1 - CYTOKINETICS INCf54965exv23w1.htm
EX-31.2 - EX-31.2 - CYTOKINETICS INCf54965exv31w2.htm
EX-10.76 - EX-10.76 - CYTOKINETICS INCf54965exv10w76.htm
EX-31.1 - EX-31.1 - CYTOKINETICS INCf54965exv31w1.htm
Exhibit 32.1
CEO and CFO CERTIFICATIONS PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. Section 1350)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Robert I. Blum, President, Chief Executive Officer and Director, and Sharon A. Barbari, Chief Financial Officer, of Cytokinetics, Incorporated (the “Company”), hereby certify that to the best of our knowledge:
1. The Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and to which this certification is attached as Exhibit 32.1 (the “Annual Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
2. The information contained in this Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
  By:   /s/ Robert I. Blum    
    Robert I. Blum,   
    President, Chief Executive Officer and Director (Principal Executive Officer)   
 
     
  By:   /s/ Sharon A. Barbari    
    Sharon A. Barbari,   
    Executive Vice President, Finance and Chief Financial Officer (Principal Financial Officer)   
 
Date: March 11, 2010